Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Pulmonology
•
Pulmonary Infections
How do you manage a 3 cm solitary pulmonary cryptococcoma in an asymptomatic, immunocompetent, HIV-negative host?
Related Questions
What is the interpretation of two IGRAs with negative mitogen wells, in the absence of immunosuppression?
What is your approach to prescribing RIPE for 6 month vs rifapentine/moxifloxacin for 4 months in the treatment of drug sensitive TB in the US?
Have you incorporated the use of steroids for patients with severe community-acquired pneumonia?
How would you approach treatment of latent TB for patients who cannot tolerate rifamycins or isoniazid due to allergy, intolerance, or drug-drug interactions?
What is the interpretation of an IGRA with positive TB wells and negative nil and negative mitogen wells?
How would you treat a patient with psoriatic arthritis who developed disseminated histoplasmosis while on adalimumab and previously failed all non-biologic DMARDs?
Do you administer prophylactic antibiotics to prevent VAP following intubation in patients with acute brain injury?
Does your institution have formal policies or work flows to reduce unnecessary IGRAs ordered for patients on biologics?
Do you treat non-albicans strains of Candida on sputum culture or BAL in patients who are immunosuppressed?
What is your approach to duration of antibiotic therapy for treatment of a bacterial lung abscess?
